Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $46,387 | 14 | 98.2% |
| Food and Beverage | $871.72 | 46 | 1.8% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Applied Therapeutics, inc. | $46,244 | 13 | $0 (2022) |
| Novo Nordisk Inc | $239.19 | 12 | $0 (2024) |
| Lilly USA, LLC | $153.05 | 11 | $0 (2024) |
| Eli Lilly and Company | $142.50 | 1 | $0 (2020) |
| PFIZER INC. | $81.91 | 3 | $0 (2024) |
| Dynavax Technologies Corporation | $46.74 | 2 | $0 (2024) |
| Dexcom, Inc. | $41.80 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $41.80 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $40.21 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $39.67 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $777.07 | 41 | Novo Nordisk Inc ($207.41) |
| 2022 | $11,323 | 6 | Applied Therapeutics, inc. ($11,309) |
| 2021 | $34,935 | 8 | Applied Therapeutics, inc. ($34,935) |
| 2020 | $142.50 | 1 | Eli Lilly and Company ($142.50) |
| 2019 | $14.36 | 1 | Novo Nordisk Inc ($14.36) |
| 2017 | $66.00 | 3 | AstraZeneca Pharmaceuticals LP ($24.82) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: VACCINES | ||||||
| 10/28/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: VACCINES | ||||||
| 10/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Endocrinology | ||||||
| 10/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Obesity | ||||||
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Obesity | ||||||
| 09/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Oncology | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: UROLOGY | ||||||
| 06/20/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: VACCINE | ||||||
| 06/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: VACCINES | ||||||
| 06/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 06/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $0.21 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Hepatitis B Vaccine | ||||||
| 06/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Obesity | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy | Applied Therapeutics, inc. | $46,244 | 13 |
| A PHASE 2, PARALLEL, COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS | Eli Lilly and Company | $142.50 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 83 | 162 | $31,282 | $13,039 |
| 2022 | 3 | 103 | 195 | $37,937 | $17,979 |
| 2021 | 2 | 62 | 105 | $20,031 | $7,098 |
| 2020 | 2 | 85 | 180 | $32,482 | $10,905 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 103 | $21,424 | $8,065 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 40 | $5,640 | $2,493 | 44.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 19 | 19 | $4,218 | $2,481 | 58.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 122 | $25,376 | $11,202 | 44.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 28 | 28 | $6,216 | $3,801 | 61.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 45 | $6,345 | $2,976 | 46.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 78 | $16,224 | $5,649 | 34.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 27 | $3,807 | $1,449 | 38.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 45 | 106 | $22,048 | $7,158 | 32.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 40 | 74 | $10,434 | $3,747 | 35.9% |
About Dr. Audrey Lacour, M.D
Dr. Audrey Lacour, M.D is a Family Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437190774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Audrey Lacour, M.D has received a total of $47,258 in payments from pharmaceutical and medical device companies, with $777.07 received in 2024. These payments were reported across 60 transactions from 19 companies. The most common payment nature is "" ($46,387).
As a Medicare-enrolled provider, Lacour has provided services to 333 Medicare beneficiaries, totaling 642 services with total Medicare billing of $49,021. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Houston, TX
- Active Since 06/09/2006
- Last Updated 01/27/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1437190774
Products in Payments
- MOUNJARO (Drug) $94.25
- Ozempic (Drug) $88.84
- PREVNAR 20 (Biological) $81.91
- Rybelsus (Drug) $62.41
- JARDIANCE (Drug) $58.80
- Wegovy (Drug) $56.16
- Heplisav-B (Drug) $46.74
- Dexcom G6 Transmitter (Medical Supply) $41.80
- GARDASIL (Biological) $41.80
- Veozah (Drug) $39.67
- Cologuard Collection Kit (Device) $35.69
- FARXIGA (Drug) $24.82
- Belviq (Drug) $23.76
- VOQUEZNA (Drug) $21.88
- CREON (Drug) $20.25
- SHINGRIX (Biological) $19.94
- ACCRUFER (Drug) $19.55
- GEMTESA (Drug) $18.33
- Victoza (Drug) $17.42
- AIRSUPRA (Drug) $15.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Houston
Shannon Schrader, Md, MD
Family Medicine — Payments: $383,042
Dr. Eric Nolen, Md, Mba, MD, MBA
Family Medicine — Payments: $158,026
Candice Winful, M.d, M.D
Family Medicine — Payments: $123,290
Dr. Joe Pouzar, M.d, M.D
Family Medicine — Payments: $104,957
Victor Escobar, M.d, M.D
Family Medicine — Payments: $79,840
Dr. Oscar De Valle, M.d, M.D
Family Medicine — Payments: $78,226